Alex Andrianopoulos

GP and Chief Research and Diligence Officer at Kairos Ventures · Los Angeles, United States

Invests in AI

Alex Andrianopoulos's investor profile lists AI alongside Healthcare & Biotech, Biotech & Pharma and MedTech & Medical Devices, at early-stage venture. The record holds 14 deals, among them Actuate Therapeutics, Inc., Siege Pharmaceuticals and KMLabs Inc..

Email Investor

Email Investor

Credits to line up before an early-stage round

Alex Andrianopoulos backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Actuate Therapeutics, Inc.
  • Siege Pharmaceuticals
  • KMLabs Inc.
  • Novosteo Inc
  • Multiversal Ventures
  • Actinobac Biomed, Inc.
  • AtScale, Inc.
  • Mineshare
  • Pinpoint Therapeutics
  • Xidas Inc.
  • Actinia, Inc.
  • Applaud Medical, Inc.
  • Vivodyne
  • NVasc

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, MedTech & Medical Devices, Crypto & Web3, SaaS & Enterprise
Rounds
Early-stage venture
Profile
Venture investor
Deals on record
14
Based in
Los Angeles, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Alex Andrianopoulos invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Alex Andrianopoulos's investor profile, together with Healthcare & Biotech, Biotech & Pharma and MedTech & Medical Devices. The stages on record are early-stage venture.
Which companies has Alex Andrianopoulos backed?
The record lists 14 deals, including Actuate Therapeutics, Inc., Siege Pharmaceuticals, KMLabs Inc., Novosteo Inc and Multiversal Ventures. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Alex Andrianopoulos?
For a company raising an early-stage round, AI Perks lists credits such as Confluent (up to $20,000), Vercel (up to $850,000), Deepgram (up to $100,000) and Gemini (up to $350,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor